Come Dec. 15, local investors will have to complete an hour-long mandatory online training before investing in leveraged or ...

Despite market pressures, QinetiQ Group PLC (QNTQF) secures significant contracts and maintains a robust pipeline for future ...

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data ...

Q3 2025 Earnings Call November 5, 2025 4:00 AM ESTCompany ParticipantsMattias Frithiof - Senior Vice President of ...

Investing.com -- J Sainsbury Plc (LON:SBRY) on Thursday lifted its full-year profit outlook after reporting higher first-half ...

Strong performance, including robust free cash flow generation and continued margin expansion, reflecting disciplined execution and operational efficiency.Marked the one-year anniversary of the POWER ...

Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and ...

Q3 2025 Earnings Call November 6, 2025 9:00 AM ESTCompany ParticipantsAdam Strachan - Head of Investor RelationsIan Lowitt - Group ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

A conference call to discuss the Company's Q3 2025 operational and financial results will be held on Friday, November 7, 2025, at 8:00 a.m. PT / 11:00 a.m. ET. To participate in the conference call or ...